Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS1 | P23219 | 1/20 | 0.77 |
| ▸ | TBXAS1 | P24557 | 1/20 | 0.77 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.77 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.77 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.77 |
| ▸ | STK39 | Q9UEW8 | 11/20 | 0.70 |
| ▸ | PNLIP | P16233 | 1/20 | 0.69 |
| ▸ | P2RX1 | P51575 | 1/20 | 0.66 |
| ▸ | PARG | Q86W56 | 3/20 | 0.64 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.60 |
| ▸ | CTSD | P07339 | 2/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL649911 | 1.00 | PTGS1 (0.77) | PTGS1TBXAS1MAPK1PTGS2MAPK14 | |
| SCHEMBL21570088 | 0.91 | STK39 (0.85) | PTGS1TBXAS1MAPK1PTGS2MAPK14 | |
| SCHEMBL11692717 | 0.89 | PTGS1 (0.71) | PTGS1TBXAS1MAPK1PTGS2MAPK14 | |
| SCHEMBL10457403 | 0.89 | PARG (0.71) | PTGS1TBXAS1MAPK1PTGS2MAPK14 | |
| SCHEMBL25413048 | 0.89 | PTGS1 (0.71) | PTGS1TBXAS1MAPK1PTGS2MAPK14 | |
| SCHEMBL9868077 | 0.89 | STK39 (0.77) | PTGS1TBXAS1MAPK1PTGS2MAPK14 | |
| 3,3',4',5-Tetrachlorosalicylanilide SCHEMBL29367227 | 0.87 | PTGS1 (1.00) | PTGS1TBXAS1MAPK1PTGS2MAPK14 | |
| 3,3',4',5-Tetrachlorosalicylanilide SCHEMBL168748 | 0.87 | PTGS1 (1.00) | PTGS1TBXAS1MAPK1PTGS2MAPK14 | |
| Hydrochloric Acid SCHEMBL11777767 | 0.87 | STK39 (0.75) | PTGS1TBXAS1MAPK1PTGS2MAPK14 | |
| SCHEMBL29211122 | 0.85 | P2RX1 (0.64) | PTGS1TBXAS1MAPK1PTGS2MAPK14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250376550-A1 | PARTICLES USED FOR FORMATION OF PICKERING EMULSION OR LIKE | KIRIN HOLDINGS KABUSHIKI KAISHA (JP) | 2025-12-11 | — | — | US | disclosed |
| EP-4538328-A1 | PARTICLES USED FOR FORMATION OF PICKERING EMULSION OR LIKE | KIRIN HOLDINGS KABUSHIKI KAISHA (JP) | 2025-04-16 | — | — | EP | disclosed |
| WO-2023243633-A1 | PARTICLES USED FOR FORMATION OF PICKERING EMULSION OR LIKE | キリンホールディングス株式会社 | 2023-12-21 | — | — | WO | disclosed |
| US-11844813-B2 | Ligand regulated protein-protein interaction system | ST. ANNA KINDERKREBSFORSCHUNG (AT) | 2023-12-19 | — | — | US | disclosed |
| US-20220041687-A1 | A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) | ST. ANNA KINDERKREBSFORSCHUNG (AT) | 2022-02-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220041687-A1 | A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) | CARS1, CD74, HAVCR2 | PTGS1 3901/4885TBXAS1 4256/4885MAPK1 4128/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.